These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24023968)

  • 1. Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis.
    Cao Y; Xu W; Xiong S
    PLoS One; 2013; 8(9):e74955. PubMed ID: 24023968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-22-producing Th22 cells play a protective role in CVB3-induced chronic myocarditis and dilated cardiomyopathy by inhibiting myocardial fibrosis.
    Guo Y; Wu W; Cen Z; Li X; Kong Q; Zhou Q
    Virol J; 2014 Dec; 11():230. PubMed ID: 25547181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway.
    Shi Y; Fukuoka M; Li G; Liu Y; Chen M; Konviser M; Chen X; Opavsky MA; Liu PP
    Circulation; 2010 Jun; 121(24):2624-34. PubMed ID: 20530002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo delivery of adenoviral vector containing interleukin-17 receptor a reduces cardiac remodeling and improves myocardial function in viral myocarditis leading to dilated cardiomyopathy.
    Xie Y; Li M; Wang X; Zhang X; Peng T; Yang Y; Zou Y; Ge J; Chen H; Chen R
    PLoS One; 2013; 8(8):e72158. PubMed ID: 23977238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and interleukin-1β increase cardiac remodeling during coxsackievirus B3 myocarditis via serpin A 3n.
    Coronado MJ; Brandt JE; Kim E; Bucek A; Bedja D; Abston ED; Shin J; Gabrielson KL; Mitzner W; Fairweather D
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1726-36. PubMed ID: 22328081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of CVB3 myocarditis in C57BL/6J mice: an extended in-depth characterization.
    Favere K; Van Hecke M; Eens S; Bosman M; Stobbelaar K; Hotterbeekx A; Kumar-Singh S; L Delputte P; Fransen E; De Sutter J; Guns PJ; Roskams T; Heidbuchel H
    Cardiovasc Pathol; 2024; 72():107652. PubMed ID: 38750778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance.
    Jin H; Guo X
    Virol J; 2016 Oct; 13(1):168. PubMed ID: 27724948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.
    Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S
    PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-37 Ameliorates Coxsackievirus B3-induced Viral Myocarditis by Modulating the Th17/Regulatory T cell Immune Response.
    An B; Liu X; Li G; Yuan H
    J Cardiovasc Pharmacol; 2017 May; 69(5):305-313. PubMed ID: 28207428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
    Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
    Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
    Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
    Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis.
    Pappritz K; Savvatis K; Miteva K; Kerim B; Dong F; Fechner H; Müller I; Brandt C; Lopez B; González A; Ravassa S; Klingel K; Diez J; Reinke P; Volk HD; Van Linthout S; Tschöpe C
    FASEB J; 2018 Jun; ():fj201701408R. PubMed ID: 29863913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Huang Y; Huang X; Wei Z; Dong J; Lu J; Tang Q; Lu F; Cen Z; Wu W
    Int Immunopharmacol; 2024 Jan; 127():111304. PubMed ID: 38091826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of endurance exercise training on myocardial fibrosis and arrhythmogenesis in a coxsackievirus B3 myocarditis mouse model.
    Favere K; Van Hecke M; Eens S; Bosman M; Delputte PL; De Sutter J; Fransen E; Roskams T; Guns PJ; Heidbuchel H
    Sci Rep; 2024 Jun; 14(1):12653. PubMed ID: 38825590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.
    Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ
    Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadectomy of male BALB/c mice increases Tim-3(+) alternatively activated M2 macrophages, Tim-3(+) T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis.
    Frisancho-Kiss S; Coronado MJ; Frisancho JA; Lau VM; Rose NR; Klein SL; Fairweather D
    Brain Behav Immun; 2009 Jul; 23(5):649-57. PubMed ID: 19126426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
    Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
    Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.